Abstract
HEPARIN and Dicumarol are at present widely used in the prevention and treatment of thromboembolic diseases. The former has maintained its place, despite its expense, because of its predictability, rapidity of anticoagulant effect and lack of side reactions. Since heparin is excreted or neutralized by the body in a few hours, it must be given continuously or intermittently over relatively short periods of time. Only the parenteral route has been found effective. The standard method has been the constant intravenous drip of 200 to 300 mg. in 1.5 liters of intravenous solution daily, as reported by Murray.1 , 2 Intermittent intravenous heparin, . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
